Technical Briefs on Multipurpose Prevention Technologies
Multipurpose Prevention Technologies (MPTs)—products designed to deliver protection against HIV, other STIs, and unintended pregnancy in varied combinations—have evolved into an exciting field of research that holds great promise for improving sexual and reproductive health. Developing and evaluating MPTs is complex, and raises questions and challenges in the areas of product development, research and testing, and regulatory approval.
Working in collaboration with PATH, the Initiative for Multipurpose Prevention Technologies (IMPT), a project of PHI's CAMI Health, has released three new technical briefs focusing on the role of communications and advocacy to advance the MPT field, MPT end-user contexts, and advancing the MPT scientific agenda.
Download the briefs
MPTs: Building Momentum Through Awareness-Raising and Advocacy: Since MPTs are a new area of product development and research, the IMPT Secretariat and its partners developed presentations, resource tools, and fact sheets that helped raise awareness about MPTs, and outlined the value proposition for these products.
Building Capacity for MPT Product Development: Products developed with the needs and realities of consumers and the systems where they will be distributed have a greater likelihood of uptake and acceptability. While simple on its face, this principle has not always been included in development of consumer health products or interventions.
- Building MPT Acceptability During Product Development Through Consumer and Health Systems Research: Building upon decades of contraceptive and microbicide research, MPTs are growing into an exciting strategy for improving SRH, with dozens of products in development, close to two dozen products in development, nearly a dozen in clinical studies, and partners from 15 countries.